Patent details

EP3716979 Title: COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

Basic Information

Publication number:
EP3716979
PCT Application Number:
EP2018082947
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP188148217
PCT Publication Number:
WO2019106066
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH AN SGLT-2 INHIBITOR FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES
French Title of Invention:
COMBINAISON D'UN DÉRIVÉ DE 4-PYRIMIDINESULFAMIDE AVEC UN INHIBITEUR DE SGLT-2 POUR LE TRAITEMENT DE MALADIES LIÉES À L'ENDOTHÉLINE
German Title of Invention:
KOMBINATIONEN EINES 4-PYRIMIDINSULFAMIDDERIVATS MIT EINEM SGLT-2-INHIBITOR ZUR BEHANDLUNG VON ENDOTHELINBEDINGTEN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
29/11/2018
Grant date:
09/04/2025
EP Publication Date:
07/10/2020
PCT Publication Date:
06/06/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/04/2025
EP B1 Publication Date:
09/04/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
29/11/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/04/2025
 
 

Name:
Idorsia Pharmaceuticals Ltd
Address:
Hegenheimermattweg 91, 4123 Allschwil, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/06/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
IGLARZ, Marc
Address:
Switzerland (CH)

2

Name:
BELLET, Marc
Address:
Switzerland (CH)

Priority

Priority Number:
PCT/EP2017/081050
Priority Date:
30/11/2017
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
A61K 31/506; A61K 31/70; A61K 31/7042; A61K 31/7048; A61K 31/7056; A61P 9/10; A61P 17/02; A61P 13/12; A61P 9/12; A61P 3/10;

Publication

European Patent Bulletin

Issue number:
202515
Publication date:
09/04/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/11/2025
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
30/05/2025 Power Of Attorney 1
11/06/2025 Outgoing Correspondence 1